Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenue:    
Products, services, other $ 454,350 $ 359,364
Grant revenue 56,128 80,770
Total revenue 510,478 440,134
Costs and expenses:    
Cost of products and services 221,699 190,783
Research and development 335,270 231,923
Selling and marketing 191,236 166,223
General and administrative 808,218 726,024
Total operating costs and expenses 1,556,423 1,314,953
Operating loss (1,045,945) (874,819)
Other (expense) income:    
Interest expense, net (835,144) (605,585)
Other expense (912) (36,913)
Change in fair value of derivative liabilities (4,068,390) (530,138)
Total other (expense) income (4,904,446) (1,172,636)
Net loss $ (5,950,391) (2,047,455)
Accrued dividends on convertible preferred stock (16,668)
Net loss applicable to common shareholders $ (5,950,391) $ (2,064,123)
Net loss per share attributable to common stockholders - basic and diluted $ (0.26) $ (0.11)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 23,198,360 18,840,390